abeautytips.com
Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression - A Beauty Tips
October 28, 2017 Sunovion Pharmaceuticals Inc. (Sunovion) today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda® (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar …